Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · IEX Real-Time Price · USD
3.270
-0.080 (-2.39%)
At close: Apr 17, 2024, 4:00 PM
3.460
+0.190 (5.81%)
Pre-market: Apr 18, 2024, 4:35 AM EDT
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $72.57 million as of April 17, 2024. Its market cap has increased by 159.17% in one year.
Market Cap
72.57M
Enterprise Value
54.00M
1-Year Change
159.17%
Ranking
Category
Stock Price
$3.27
Market Cap Chart
Since November 12, 2012, Tempest Therapeutics's market cap has decreased from $107.00M to $72.57M, a decrease of -32.18%. That is a compound annual growth rate of -3.34%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 16, 2024 | 74.30M | 0.27% |
Apr 15, 2024 | 74.10M | -7.03% |
Apr 12, 2024 | 79.70M | -6.67% |
Apr 11, 2024 | 85.40M | 3.39% |
Apr 10, 2024 | 82.60M | -3.84% |
Apr 9, 2024 | 85.90M | -2.94% |
Apr 8, 2024 | 88.50M | 7.14% |
Apr 5, 2024 | 82.60M | -17.32% |
Apr 4, 2024 | 99.90M | -12.14% |
Apr 3, 2024 | 113.70M | 0.62% |
Apr 2, 2024 | 113.00M | -6.38% |
Apr 1, 2024 | 120.70M | 39.06% |
Mar 28, 2024 | 86.80M | 5.47% |
Mar 27, 2024 | 82.30M | - |
Mar 26, 2024 | 82.30M | 1.86% |
Mar 25, 2024 | 80.80M | - |
Mar 22, 2024 | 80.80M | 3.72% |
Mar 21, 2024 | 77.90M | -6.59% |
Mar 20, 2024 | 83.40M | 0.48% |
Mar 19, 2024 | 83.00M | 11.41% |
Mar 18, 2024 | 74.50M | 6.28% |
Mar 15, 2024 | 70.10M | 6.21% |
Mar 14, 2024 | 66.00M | 1.23% |
Mar 13, 2024 | 65.20M | 0.15% |
Mar 12, 2024 | 65.10M | - |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
SELLAS Life Sciences Group | 74.84M |
Asensus Surgical | 74.80M |
Cidara Therapeutics | 74.73M |
Cognition Therapeutics | 74.49M |
AN2 Therapeutics | 74.43M |
HOOKIPA Pharma | 73.38M |
Carisma Therapeutics | 73.11M |
Corvus Pharmaceuticals | 72.09M |